GlassScriptPhysician profile
Jennifer Flick
NPI 1497361034
$4,738.41
in general payments reported to CMS, 2019-2025
28 companies · $1,780 in 2025
The $1,780 reported for 2025 was more than what 93% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $538 · 2022: $1,049 · 2023: $661 · 2024: $710 · 2025: $1,780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,817 · Travel and Lodging: $332 · Education: $2.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,816.72 |
| Travel and Lodging | $331.60 |
| Education | $2.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,043.02 | 2021-2025 | Watchman Flx, Watchman Access System, Eluvia |
| Atricure, INC. | $878.07 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Biotronik INC. | $458.87 | 2025 | Acticor 7 Vr-T Dx, Biomonitor, Amvia Edge |
| Novartis Pharmaceuticals Corporation | $360.73 | 2021-2024 | |
| Pfizer INC. | $269.79 | 2022-2024 | |
| Amgen INC. | $209.61 | 2022-2025 | Repatha |
| Janssen Pharmaceuticals, INC | $201.63 | 2021-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $174.33 | 2021-2023 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $166.00 | 2021-2023 | Farxiga |
| Cleerly, INC. | $143.65 | 2024 | Cleerly Labs, Cleerly Ischemia |
| E.R. Squibb & Sons, L.L.C. | $122.33 | 2022-2024 | Camzyos, Eliquis |
| Philips North America LLC | $95.04 | 2022 | |
| Alnylam Pharmaceuticals INC. | $86.36 | 2022 | |
| Edwards Lifesciences Corporation | $78.49 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.58 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $50.08 | 2022 | |
| Mallinckrodt Hospital Products INC. | $49.77 | 2023 | Acthar |
| Bayer Healthcare Pharmaceuticals INC. | $44.11 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $41.03 | 2024 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $32.77 | 2022-2023 | |
| Medtronic, INC. | $29.68 | 2023 | Linq II |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.14 | 2022 | |
| Scpharmaceuticals INC. | $27.45 | 2024 | |
| Shockwave Medical, INC | $26.33 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Becton, Dickinson and Company | $24.81 | 2025 | Hemosphere |
| Cardiovascular Systems INC. | $19.21 | 2022 | |
| Astellas Pharma US INC | $17.71 | 2022 | |
| Cvrx, INC. | $4.82 | 2023 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Flick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.